l-carnitine side effects hair loss Benefits, Sources, and Can L-Carnitine Cause Side Effects?
Description
Mitochondrial impairments in aetiopathology of multifactorial diseases: common origin but individual outcomes in context of 3P medicine

doi:10.3389/fnagi.2015.00166

& Guan, K

This clinical presentation is most common with VEGFR inhibitors, occurring in 60% of regorafenib patients, 35.5% of patients in treatment with cabozantinib, and 27% of patients with lenvatinib, and is also frequently observed with sunitinib, sorafenib, and pazopanib
